Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy.

Echchannaoui, Hakim; Perreau, Matthieu; Schild, Hansjörg; Theobald, Matthias

Echchannaoui, Hakim; Perreau, Matthieu; Schild, Hansjörg; Theobald, Matthias.

Afiliação

Echchannaoui H; Department of Hematology and Medical Oncology, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany.
Perreau M; German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, Mainz, Germany.
Schild H; Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Theobald M; Institute of Immunology, UMC of the Johannes Gutenberg University, Mainz, Germany.

Front Immunol ; 15: 1450555, 2024.

Article em En | MEDLINE | ID: mdl-39011041

Assuntos

Imunoterapia; Neoplasias; Humanos; Neoplasias/imunologia; Neoplasias/terapia; Imunoterapia/métodos; Doença Crônica; Animais; Evasão Tumoral; Evasão da Resposta Imune

Palavras-chave

chronic infection; cutting edge technologies; immune evasion; immunotherapy; metabolism; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google